MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 215 filers reported holding MEDICINES CO in Q1 2019. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $48,847,000 | +417.3% | 575,106 | +204.6% | 0.03% | +440.0% |
| Q3 2019 | $9,443,000 | +79.6% | 188,829 | +31.0% | 0.01% | +66.7% |
| Q2 2019 | $5,259,000 | +44.1% | 144,148 | +10.4% | 0.00% | 0.0% |
| Q1 2019 | $3,650,000 | +74.0% | 130,546 | +19.1% | 0.00% | +50.0% |
| Q4 2018 | $2,098,000 | -31.5% | 109,577 | +7.0% | 0.00% | 0.0% |
| Q3 2018 | $3,064,000 | +60.2% | 102,397 | +96.5% | 0.00% | 0.0% |
| Q2 2018 | $1,913,000 | +140.3% | 52,122 | +115.6% | 0.00% | +100.0% |
| Q1 2018 | $796,000 | -57.3% | 24,175 | -64.5% | 0.00% | 0.0% |
| Q4 2017 | $1,863,000 | -66.5% | 68,171 | -54.6% | 0.00% | -80.0% |
| Q3 2017 | $5,566,000 | +53.2% | 150,275 | +57.2% | 0.01% | +25.0% |
| Q2 2017 | $3,633,000 | -81.2% | 95,585 | -75.8% | 0.00% | -81.0% |
| Q1 2017 | $19,314,000 | +1436.5% | 394,948 | +967.1% | 0.02% | +2000.0% |
| Q4 2016 | $1,257,000 | -86.1% | 37,012 | -84.6% | 0.00% | -90.0% |
| Q3 2016 | $9,059,000 | +277.0% | 240,007 | +235.9% | 0.01% | +233.3% |
| Q2 2016 | $2,403,000 | +84.7% | 71,460 | +70.3% | 0.00% | +50.0% |
| Q1 2016 | $1,301,000 | -76.4% | 41,958 | -71.9% | 0.00% | -71.4% |
| Q4 2015 | $5,521,000 | +17.8% | 149,226 | +17.9% | 0.01% | +40.0% |
| Q3 2015 | $4,685,000 | +210.7% | 126,621 | +135.1% | 0.01% | +150.0% |
| Q2 2015 | $1,508,000 | -53.7% | 53,852 | -53.7% | 0.00% | -50.0% |
| Q1 2015 | $3,256,000 | +126.7% | 116,294 | +118.8% | 0.00% | +300.0% |
| Q4 2014 | $1,436,000 | -51.4% | 53,160 | -60.4% | 0.00% | -66.7% |
| Q3 2014 | $2,955,000 | -23.1% | 134,324 | +1.4% | 0.00% | -25.0% |
| Q2 2014 | $3,841,000 | +171.6% | 132,475 | +162.3% | 0.00% | +100.0% |
| Q1 2014 | $1,414,000 | -81.2% | 50,502 | -74.5% | 0.00% | -75.0% |
| Q4 2013 | $7,521,000 | +100.3% | 197,932 | +74.0% | 0.01% | +60.0% |
| Q3 2013 | $3,755,000 | +62.9% | 113,779 | +51.9% | 0.01% | +66.7% |
| Q2 2013 | $2,305,000 | – | 74,909 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
| SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
| Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
| Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
| RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
| DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
| Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
| WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
| Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
| Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |